Literature DB >> 12871469

Role of in vitro cholesterol depletion in mediating human platelet aggregation.

S Grgurevich1, R Krishnan, M M White, L K Jennings.   

Abstract

We investigated the direct role of cholesterol lowering on human platelet aggregation by in vitro cholesterol depletion using methyl-beta-cyclodextrin. Collagen and thrombin receptor agonist peptide induced maximal aggregation was significantly decreased in cholesterol depleted platelets. In contrast, anti-CD9 antibody, mAb7, or anti-beta(3) antibody, D3, induced percent maximal aggregation was unaffected by cholesterol depletion. Surface and total alpha(IIb)beta(3) levels were equivalent in both groups. Morphological and ultrastructural analysis of collagen induced aggregates revealed that normal and cholesterol depleted platelets changed shape and aggregated; however, cholesterol depletion impaired microtubule ring formation and aggregate size. Cholesterol depletion also diminished the extent of the open canalicular system and collagen induced platelet ATP release. These data suggest cholesterol depletion impairs platelet aggregation by altering platelet ultrastructure critical in mediating secretion. Temporal differences and differences in tyrosine phosphoprotein levels following collagen stimulation were observed, thereby indicating that platelet signaling was concurrently affected by cholesterol depletion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12871469     DOI: 10.1046/j.1538-7836.2003.00087.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  6 in total

1.  The platelet receptor for type III collagen (TIIICBP) is present in platelet membrane lipid microdomains (rafts).

Authors:  Pascal Maurice; Ludovic Waeckel; Viviane Pires; Pascal Sonnet; Monique Lemesle; Brigitte Arbeille; Jany Vassy; Jacques Rochette; Chantal Legrand; Françoise Fauvel-Lafève
Journal:  Histochem Cell Biol       Date:  2005-10-05       Impact factor: 4.304

2.  Variations in Fusion Pore Formation in Cholesterol-Treated Platelets.

Authors:  Solaire A Finkenstaedt-Quinn; Sarah M Gruba; Christy L Haynes
Journal:  Biophys J       Date:  2016-02-23       Impact factor: 4.033

3.  Chromium picolinate inhibits cholesterol-induced stimulation of platelet aggregation in hypercholesterolemic rats.

Authors:  A A Seif
Journal:  Ir J Med Sci       Date:  2014-03-15       Impact factor: 1.568

4.  Dynamic cycling of t-SNARE acylation regulates platelet exocytosis.

Authors:  Jinchao Zhang; Yunjie Huang; Jing Chen; Haining Zhu; Sidney W Whiteheart
Journal:  J Biol Chem       Date:  2018-01-19       Impact factor: 5.157

Review 5.  Antiatherosclerotic Effects of CSL112 Mediated by Enhanced Cholesterol Efflux Capacity.

Authors:  Bronwyn A Kingwell; Stephen J Nicholls; Elena Velkoska; Svetlana A Didichenko; Danielle Duffy; Serge Korjian; C Michael Gibson
Journal:  J Am Heart Assoc       Date:  2022-04-12       Impact factor: 6.106

6.  Lentiviral gene therapy corrects platelet phenotype and function in patients with Wiskott-Aldrich syndrome.

Authors:  Lucia Sereni; Maria Carmina Castiello; Dario Di Silvestre; Patrizia Della Valle; Chiara Brombin; Francesca Ferrua; Maria Pia Cicalese; Loris Pozzi; Maddalena Migliavacca; Maria Ester Bernardo; Claudio Pignata; Roula Farah; Lucia Dora Notarangelo; Nufar Marcus; Lorella Cattaneo; Marco Spinelli; Stefania Giannelli; Marita Bosticardo; Koen van Rossem; Armando D'Angelo; Alessandro Aiuti; Pierluigi Mauri; Anna Villa
Journal:  J Allergy Clin Immunol       Date:  2019-03-27       Impact factor: 10.793

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.